TheEdgeResearch
Home / Stocks / VCBDQ

Vitalibis, Inc. (VCBDQ)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +900.00%
Market Cap
$227,440
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
-0.46
52-Wk Range
1.0E-4-0.0022
CEO
Steven P. Raack
Country
US
Currency
USD

Vitalibis, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Las Vegas, NV, US. The stock last traded at $0.00, up 900.00% on the session, giving a market capitalisation of $227,440. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -2257.9%. Its beta of -0.46 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.00
Price / Sales
0.75
Price / Book
-0.03
EV / EBITDA
-0.28
Gross margin
46.4%
Operating margin
-1940.5%
Net margin
-2257.9%
Return on equity
Debt / equity
-0.97
Current ratio
0.29
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
IPO date
2018-02-22
Headquarters
Las Vegas, NV, US
About Vitalibis, Inc.

Vitalibis, Inc. is a technology-driven company that specializes in developing and creating phytocannabinoid-rich hemp products, including those infused with cannabidiol (CBD). Beyond these, they also formulate personal care items and nutritional supplements. The company markets and sells these consumer goods directly under its proprietary Vitalibis brand. A key product in their portfolio is a water-soluble, phytocannabinoid-rich hemp powder. Originally established in 2014, the company was initially known as Sheng Ying Entertainment Corp. It subsequently rebranded to Vitalibis, Inc. in February 2018. Its operations are based in Las Vegas, Nevada.

Comparable companies

Vitalibis, Inc. is most often compared with the following Healthcare names:

CSTFEDNEFHOPHFHURAKRBPLNDZFMMNFFOSAPVTTFVEGGD
More research on VCBDQ
VCBDQ technical analysis VCBDQ TheEdge Score Compare against peers
Open full interactive analysis & DCF →